Skip Nav Destination
Issues
15 December 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Cancer Research
Table of Contents
Editorial
Reviews
Special Workshop
Meeting Reports
Priority Reports
Molecular Biology, Pathobiology, and Genetics
FBXO31 Is the Chromosome 16q24.3 Senescence Gene, a Candidate Breast Tumor Suppressor, and a Component of an SCF Complex
Raman Kumar; Paul M. Neilsen; Joanne Crawford; Ross McKirdy; Jaclyn Lee; Jason A. Powell; Zarqa Saif; Julie M. Martin; Marc Lombaerts; Cees J. Cornelisse; Anne-Marie Cleton-Jansen; David F. Callen
Mutually Exclusive Cyclin-Dependent Kinase 4/Cyclin D1 and Cyclin-Dependent Kinase 6/Cyclin D2 Pairing Inactivates Retinoblastoma Protein and Promotes Cell Cycle Dysregulation in Multiple Myeloma
Scott Ely; Maurizio Di Liberto; Ruben Niesvizky; Linda B. Baughn; Hearn J. Cho; Eunice N. Hatada; Daniel M. Knowles; Joseph Lane; Selina Chen-Kiang
CDC4 Mutations Occur in a Subset of Colorectal Cancers but Are Not Predicted to Cause Loss of Function and Are Not Associated with Chromosomal Instability
Zoe Kemp; Andrew Rowan; William Chambers; Noel Wortham; Sarah Halford; Oliver Sieber; Neil Mortensen; Axel von Herbay; Thomas Gunther; Mohammad Ilyas; Ian Tomlinson
Cell and Tumor Biology
γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP–Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 Pathway
Giammarco Fava; Luca Marucci; Shannon Glaser; Heather Francis; Sharon De Morrow; Antonio Benedetti; Domenico Alvaro; Julie Venter; Cynthia Meininger; Tushar Patel; Silvia Taffetani; Marco Marzioni; Ryun Summers; Ramona Reichenbach; Gianfranco Alpini
Cyclooxygenase-2 Inhibition Sensitizes Human Colon Carcinoma Cells to TRAIL-Induced Apoptosis through Clustering of DR5 and Concentrating Death-Inducing Signaling Complex Components into Ceramide-Enriched Caveolae
Sophie Martin; Darren C. Phillips; Kinga Szekely-Szucs; Lynda Elghazi; Fabienne Desmots; Janet A. Houghton
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Mediated Destruction
Adriana Eramo; Roberto Pallini; Fiorenza Lotti; Giovanni Sette; Mariella Patti; Monica Bartucci; Lucia Ricci-Vitiani; Michele Signore; Giorgio Stassi; Luigi M. Larocca; Lucio Crinò; Cesare Peschle; Ruggero De Maria
High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor
Nobukazu Fujimoto; Marie Wislez; Jie Zhang; Kentaro Iwanaga; Jennifer Dackor; Amy E. Hanna; Shailaja Kalyankrishna; Dianna D. Cody; Roger E. Price; Mitsuo Sato; Jerry W. Shay; John D. Minna; Michael Peyton; Ximing Tang; Erminia Massarelli; Roy Herbst; David W. Threadgill; Ignacio I. Wistuba; Jonathan M. Kurie
The Critical Role of 15-Lipoxygenase-1 in Colorectal Epithelial Cell Terminal Differentiation and Tumorigenesis
Imad Shureiqi; Yuanqing Wu; Dongning Chen; Xiu L. Yang; Baoxiang Guan; Jeffrey S. Morris; Peiying Yang; Robert A. Newman; Russell Broaddus; Stanley R. Hamilton; Patrick Lynch; Bernard Levin; Susan M. Fischer; Scott M. Lippman
Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia
Daisy W.J. van der Schaft; Femke Hillen; Patrick Pauwels; Dawn A. Kirschmann; Karolien Castermans; Mirjam G.A. oude Egbrink; Maxine G.B. Tran; Rafael Sciot; Esther Hauben; Pancras C.W. Hogendoorn; Olivier Delattre; Patrick H. Maxwell; Mary J.C. Hendrix; Arjan W. Griffioen
The G691S RET Polymorphism Increases Glial Cell Line–Derived Neurotrophic Factor–Induced Pancreatic Cancer Cell Invasion by Amplifying Mitogen-Activated Protein Kinase Signaling
Hirozumi Sawai; Yuji Okada; Kevork Kazanjian; Joseph Kim; Sascha Hasan; Oscar J. Hines; Howard A. Reber; Dave S.B. Hoon; Guido Eibl
Papillomavirus E2 Protein Induces Expression of the Matrix Metalloproteinase-9 via the Extracellular Signal-Regulated Kinase/Activator Protein-1 Signaling Pathway
Andreas Behren; Christian Simon; Roxana Michaela Schwab; Ekaterina Loetzsch; Stephan Brodbeck; Evamaria Huber; Frank Stubenrauch; Hans Peter Zenner; Thomas Iftner
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Multiple Repair Pathways Mediate Tolerance to Chemotherapeutic Cross-linking Agents in Vertebrate Cells
Kuniharu Nojima; Helfrid Hochegger; Alihossein Saberi; Toru Fukushima; Koji Kikuchi; Michio Yoshimura; Brian J. Orelli; Douglas K. Bishop; Seiki Hirano; Mioko Ohzeki; Masamichi Ishiai; Kazuhiko Yamamoto; Minoru Takata; Hiroshi Arakawa; Jean-Marie Buerstedde; Mitsuyoshi Yamazoe; Takuo Kawamoto; Kasumi Araki; Jun A. Takahashi; Nobuo Hashimoto; Shunichi Takeda; Eiichiro Sonoda
Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40–Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications
Yu-Tzu Tai; Xian-Feng Li; Laurence Catley; Rory Coffey; Iris Breitkreutz; Jooeun Bae; Weihua Song; Klaus Podar; Teru Hideshima; Dharminder Chauhan; Robert Schlossman; Paul Richardson; Steven P. Treon; Iqbal S. Grewal; Nikhil C. Munshi; Kenneth C. Anderson
BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing Tumors
David D. Gibbs; Davinder S. Theti; Nadya Wood; Matthew Green; Florence Raynaud; Melanie Valenti; Martin D. Forster; Fraser Mitchell; Vassilios Bavetsias; Elisa Henderson; Ann L. Jackman
Immunology
Activation of Tumor-Associated Macrophages by the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid Induces an Effective CD8+ T-Cell–Mediated Antitumor Immune Response in Murine Models of Lung Cancer and Mesothelioma
Arminder S. Jassar; Eiji Suzuki; Veena Kapoor; Jing Sun; Michael B. Silverberg; Lumei Cheung; Marie D. Burdick; Robert M. Strieter; Lai-Ming Ching; Larry R. Kaiser; Steven M. Albelda
Endocrinology
Coactivation of Liver Receptor Homologue-1 by Peroxisome Proliferator-Activated Receptor γ Coactivator-1α on Aromatase Promoter II and Its Inhibition by Activated Retinoid X Receptor Suggest a Novel Target for Breast-Specific Antiestrogen Therapy
Rachid Safi; Agnes Kovacic; Stéphanie Gaillard; Yoko Murata; Evan R. Simpson; Donald P. McDonnell; Colin D. Clyne
Epidemiology and Prevention
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds